Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.25 SEK | -0.38% | -4.33% | +76.67% |
05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
Business Summary
Number of employees: 32
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 61 | 100.0 % | 6 | 100.0 % | -90.71% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
74.3
%
| - | - | 4 | 74.3 % | - |
United Kingdom
25.7
%
| 61 | 100.0 % | 1 | 25.7 % | -97.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 12-12-31 |
Chief Executive Officer | 71 | 17-05-05 | |
Nicholas Waters
FOU | Founder | 62 | 12-12-31 |
Director of Finance/CFO | 53 | 12-12-31 | |
Peder Svensson
CTO | Chief Tech/Sci/R&D Officer | 62 | 12-12-31 |
Joakim Tedroff
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-12-31 |
Susanna Waters
PRN | Corporate Officer/Principal | 58 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rein Piir
BRD | Director/Board Member | 66 | 15-12-31 |
Chairman | 66 | 19-03-31 | |
Chief Executive Officer | 71 | 17-05-05 | |
Director/Board Member | 62 | 22-12-31 | |
Veronica Wallin
BRD | Director/Board Member | 38 | 22-12-31 |
Daniel Johnsson
BRD | Director/Board Member | 60 | 22-12-31 |
Director/Board Member | 60 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 79,776 | 0 | 0 | 57.48 % |
Stock B | 1 | 51,788,630 | 29,815,943 ( 57.57 %) | 0 |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.67% | 65.6M | |
+52.45% | 797B | |
+40.75% | 628B | |
-6.85% | 351B | |
+17.68% | 323B | |
+11.00% | 300B | |
+17.11% | 244B | |
+0.90% | 223B | |
+5.27% | 163B | |
-5.26% | 153B |
- Stock Market
- Equities
- IRLAB A Stock
- Company IRLAB Therapeutics AB